Description

Simple

Information currently not available.

Clinical

Information currently not available.

Overview

Pharmacology

Indication

Investigated for use/treatment in hepatitis (viral, C).

Pharmacodynamic

Information currently not available.

Mechanism of action

A-831 has shown potent activity in the replicon assay and has an excellent therapeutic index and good pharmacokinetic properties, as well as displaying a novel mechanism of action targeting the NS5a protein.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Effect Regions Age Groups Incidences Evidence Type

Contraindications

Information currently not available.

Food Interactions

Information currently not available.